Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Ovidiu, Coza"'
Autor:
Călin Căinap, Ovidiu-Vasile Bochiş, Cătălin Vlad, Raluca Popita, Patriciu Achimaş-Cadariu, Andrei Havasi, Andreea Vidrean, Alexandra Dranca, Andra Piciu, Anne-Marie Constantin, Tiberiu Tat, Maniu Dana, Ovidiu Crişan, Cosmin Vasile Cioban, Ovidiu Bălăcescu, Ovidiu Coza, Loredana Bălăcescu, Monica Mihaela Marta, Madalina Bota, Simona Căinap
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2021)
Background: Colorectal cancer (CRC) is the third most common cancer in Europe, with an annual increase in incidence ranging between 0.4 and 3.6% in various countries. Although the development of CRC was extensively studied, limited number of new ther
Externí odkaz:
https://doaj.org/article/ba76f3bb3eab401e957edd2ddb242ff4
Autor:
Calin Cainap, Rodica Ana Ungur, Ovidiu-Vasile Bochis, Patriciu Achimas, Catalin Vlad, Andrei Havasi, Andreea Vidrean, Anca Farcas, Tiberiu Tat, Alexandra Gherman, Andra Piciu, Madalina Bota, Anne-Marie Constantin, Laura Ancuta Pop, Dana Maniu, Ovidiu Crisan, Cosmin Vasile Cioban, Ovidiu Balacescu, Ovidiu Coza, Loredana Balacescu, Monica Mihaela Marta, Eleonora Dronca, Simona Cainap
Publikováno v:
PLoS ONE, Vol 16, Iss 4, p e0248922 (2021)
Colorectal cancer remains one of the most frequent malignancies (third place at both genders) worldwide in the last decade, owing to significant changes in modern dietary habits. Approximately half of the patients develop metastases during the course
Externí odkaz:
https://doaj.org/article/e9890793171d49abb67d4df27f2aeaf7
Autor:
Alexandra Iulia Irimie, Cornelia Braicu, Sergiu Pasca, Lorand Magdo, Diana Gulei, Roxana Cojocneanu, Cristina Ciocan, Andrei Olariu, Ovidiu Coza, Ioana Berindan-Neagoe
Publikováno v:
Medicina, Vol 55, Iss 6, p 283 (2019)
Regarding cancer as a genetic multi-factorial disease, a number of aspects need to be investigated and analyzed in terms of cancer’s predisposition, development and prognosis. One of these multi-dimensional factors, which has gained increased atten
Externí odkaz:
https://doaj.org/article/e7c7fd53cdc847108de1384936f6cccd
Autor:
Cristina Alexandra Ciocan-Cartita, Ancuța Jurj, Mihail Buse, Diana Gulei, Cornelia Braicu, Lajos Raduly, Roxana Cojocneanu, Lavinia Lorena Pruteanu, Cristina Adela Iuga, Ovidiu Coza, Ioana Berindan-Neagoe
Publikováno v:
International Journal of Molecular Sciences, Vol 20, Iss 10, p 2576 (2019)
Mass spectrometry (MS) is an essential analytical technology on which the emerging omics domains; such as genomics; transcriptomics; proteomics and metabolomics; are based. This quantifiable technique allows for the identification of thousands of pro
Externí odkaz:
https://doaj.org/article/f965883d2c594e86bc386dd016d444d1
Autor:
Florin Ignat, P Achimaş Cadariu, CI Trifan, Gabriel Lazar, AT Kirsch-Mangu, C Pop, Dan Tudor Eniu, Stefan Hica, Ovidiu Coza, V Galatan, Claudia Ordeanu, A. Rancea, Nicolae Todor, Ioan-Cătălin Vlad, Viorica Nagy, A Trăilă, Diana Cristina Pop, R Bodea, Ioan Cosmin Lisencu, AP Trăilă
Publikováno v:
Vaginal and vulvar cancer.
Introduction/Background* The purpose of this study was to evaluate 5-year overall survival (OS), disease free survival (DFS) and local control (LC) for patients diagnosed with primary vulvar cancer and treated at Institute of Oncology “Prof.Dr.Ion
Autor:
Ruxandra Rajnoveanu, Claudia Militaru, Ovidiu Coza, Doina Adina Todea, Adela Patcas, Ana Florica Chis, Tamas Tiberiu, Reem Hanna, Ioana Roxana Bordea
Publikováno v:
Bosnian Journal of Basic Medical Sciences (2021)
Implementation of precision medicine in lung cancer has benefited from intense research in the past years, developing subsequently an improved quality of life and increased overall survival of the patients. Targeted therapy has become one of the most
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::02459ee0d33cc820f278b4fb3bbc4597
https://www.bjbms.org/ojs/index.php/bjbms/article/view/5859
https://www.bjbms.org/ojs/index.php/bjbms/article/view/5859
Autor:
Ovidiu-Vasile, Bochiș, Cătălin, Vlad, Călin, Căinap, Patriciu, Achimaș Cadariu, Daniel, Sur, Andrei, Havasi, Andreea, Vidrean, Alexandra, Mureșan, Andra, Piciu, Madalina, Bota, Anne Marie, Constantin, Tiberiu, Tat, Dana, Maniu, Ovidiu, Crișan, Cosmin, Vasile Cioban, Ovidiu, Bălăcescu, Ovidiu, Coza, Loredana, Bălăcescu, Monica Mihaela, Marta, Simona, Căinap
Publikováno v:
Journal of B.U.ON. : official journal of the Balkan Union of Oncology. 25(2)
Bevacizumab or cetuximab represent the standard treatment in association with classical chemotherapy in confirmed metastatic colorectal cancer (mCRC). Bevacizumab could be continued after the first disease progression with an overall survival (OS) ad
Autor:
Daniel, Sur, Ovidiu, Coza, Andrei, Havasi, Calin, Cainap, Claudia, Burz, Catalin, Vlad, Ovidiu, Balacescu, Irimie, Alexandru, Cosmin, Lisencu
Publikováno v:
Journal of B.U.ON. : official journal of the Balkan Union of Oncology. 25(1)
In this review, we focused on presenting an up-to-date overview of exosomal miRNAs as biomarkers for diagnosis, prognosis, and their therapeutically perspectives in colorectal cancer (CRC).A comprehensive literature search was conducted using the PUB
Autor:
Elvio Russi, Chiara Gasparotto, Josep M. Borràs, Laimonas Jarusevicius, J. Corral, Margit Valgma, Cai Grau, Nazia Mohammed, Mary Coffey, Elena Slobina, Felix Sedlmayer, Heikki Minn, Elvisa Kozma, Bruno Chauvet, Martin J. Rolles, Tom Roques, Snezhana Smichkoska, Judith van Loon, Tatiana Hadjieva, Noémie Defourny, Yolande Lievens, Jiri Petera, Antonio Lopez Medina, Ovidiu Coza, Michel Untereiner, Zoltan Takácsi-Nagy, Brian H Kristensen, Esther Gc Troost, Jean-François Daisne, Maria Lurdes Trigo, Julian Malicki, Vanja Karadjinovic, Vassilis Kouloulias
Publikováno v:
Lievens, Y, Defourny, N, Corral, J, Gasparotto, C, Grau, C, Borras, J M & ESTRO–HERO Consortium Collaborators 2020, ' How public health services pay for radiotherapy in Europe : an ESTRO-HERO analysis of reimbursement ', The Lancet Oncology, vol. 21, no. 1, pp. e42-e54 . https://doi.org/10.1016/S1470-2045(19)30794-6
Reimbursement is a key factor in defining which resources are made available to ensure quality, efficiency, availability, and access to specific health-care interventions. This Policy Review assesses publicly funded radiotherapy reimbursement systems
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8429be168c8a7b9fdebde73bc35cdcc0
https://pure.au.dk/portal/da/publications/how-public-health-services-pay-for-radiotherapy-in-europe(c12406a3-c5e3-4ac0-83c7-40b38e43e412).html
https://pure.au.dk/portal/da/publications/how-public-health-services-pay-for-radiotherapy-in-europe(c12406a3-c5e3-4ac0-83c7-40b38e43e412).html
Autor:
Anca Farcas, Laura Pop, Andra Piciu, Andrei Havasi, Andreea Vidrean, Calin Cainap, Tiberiu Tat, Alexandra Gherman, Monica Mihaela Marta, Ovidiu Balacescu, Madalina Bota, Catalin Vlad, Eleonora Dronca, Patriciu Achimas, Anne-Marie Constantin, Cosmin Vasile Cioban, Rodica Ungur, Loredana Balacescu, Simona Cainap, Ovidiu Coza, Ovidiu-Vasile Bochis, Dana Maniu, Ovidiu Crisan
Publikováno v:
PLoS ONE
PLoS ONE, Vol 16, Iss 4, p e0248922 (2021)
PLoS ONE, Vol 16, Iss 4, p e0248922 (2021)
Colorectal cancer remains one of the most frequent malignancies (third place at both genders) worldwide in the last decade, owing to significant changes in modern dietary habits. Approximately half of the patients develop metastases during the course